USP15 and triple-negative breast carcinoma: Then, through the UALCAN and GEPIA database, we found that USP15 in breast cancer significantly reduced the survival rate of premenopausal women (p = 0.011) and triple-negative breast cancer patients (p = 0.038) (Figure 1(d) and 1(e)).